Daniel A Goldstein

10PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 26, 2026
Variation in guideline decision-making: a cross-sectional study of oncology compendium panels.

|Jan 31, 2025
Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer.

Daniel A Goldstein, Roi Tschernichovsky, Talish Razi

|Dec 28, 2020
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.

Andrew H Briggs, Daniel A Goldstein, Erin Kirwin

|May 07, 2020
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real-world early-stage breast cancer.

Daniel A Goldstein, Chen Mayer, Tzippy Shochat

|Feb 06, 2019
The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States.

Assaf Moore, Ido Stav, Robert B Den

|Oct 31, 2018
Duration of adjuvant immunotherapy-biologic, clinical and economic considerations.

Ido Stav, Bishal Gyawali, Daniel A Goldstein

Pageof 2

Frequent Collaborators

2 joint publications

Assaf Moore

2 joint publications

Ian F Tannock

2 joint publications

Mark J Ratain

1 joint publications

Hadar Goldvaser